Hem Onc 2 Flashcards
Methotrexate applications
Breat cancer
Osteosarcoma
Lymphoma
Choriocarcinoma
Methotrexate side effects
Mylosuppression
Muscotis
Renal tox
Pemetrxed applications
Lung cancer
Pemetrexed side effects
Mylosuppression (bad)
Mucositus
Skin rash
Florouracil applications
Brest cancer
Colo rectal
Head and neck
ATRA treats:
DIC in acute promylocytic leukemia
Pre B cell disease and locations
Marrow
Acute leukoblastic leukemia/ lymphoma
Mature naive B cell disease
Cll
Mantle cell lymphoma
Germinal cell B cell diseases
Diffuse large B cell lymphoma
Focal lymphoma
Burkits
Hodgkins
Plasma cell disease
Multiple myeloma
Memory cell disease
Marginal cell lymphoma
Chronic LL
CD34
Expressed only on stem cells
Not on mature cells
Brentuximab
CD30 target
3rd line lymphoma treatment
Chemo smart bomb
Rituximab
Targets CD 20
B cell lymphoma
BCL 2
Anti apoptosis gene
mutated with t(14:18)
Mutated in follicular lymphoma
cd 20
On the surface of mature B cells
Not on the surface of b stem cells or plasma cells
CD56
Multiple myeloma marker
CD 38 and CD 138
Abnormal and normal plasma cells
Crab
Calcium
Renal
Anemia
Bone
Gemcitabine applications
Lung and pancreatic cancer
Bortzomib
Antibprotease used to treat multiple myeloma
Side effects are neuropathy- this is decreased with subcutaneous admin
Cyclophoride applications
Breast, osteosarcoma, lymphoma
Cyclophoride side effects
Mylisuppresikn
GI
Diahrrea
Cystitis because of accumulation of the chemical in the bladder
ERCC1
DNA repair enzyme
Increased for cisplatin resistance
14q32
Most common mutation in multiple myeloma
Plerixafor
Used to increase stem cells in peripheral blood
CDCR - SDF-1 antagonist
Cetuximab
Outside EGFR antibody
Lung cancer
Panitumumab
Outside EGFR antibody
Lung cancer
Erlotinib
Block internal tyrosine kinase activity of EGFR
Gefitinib
Blocks internal tyrosine kinase activity
Trastuzumab
Antibody that blocks outside tyrosine kinase activity of her2
Pertuzumab
Blocks dimerizarikn of her2
Lapatinib
Blocks internal tyrosine kinase activity of her2
Bevacizumab
Blocks extra cellular domain of VEGF
Sorafinib
Blocks internal tyrosine kinase activity of VEGF
Sunitinib
Blocks internal tyrosine kinase activity of VEGF
Diffuse large B cell lymphoma mutation
3q27
BCL-6
FL markers
Cd10
Bcl2
Most common lymphomas
Dlbcl most common
Fl 2nd
9:22
Philadelphia chromosome
Imatinib
Displaces ATP from Phillinchormoske
Burkitts Chromosome mutation
8:14
Mantle cell lymphoma mutation
11:14
T cell inhibitory interaction
B7-CLTA4
Excitatory T cell interaction
B7- CD28
Most common adult acute leukemia
aml
Xerostomia
Dry mouth
Bliomyosin toxicity
Pulmonary fibrosis
Adriamycin side effect
Cardiac toxicity
CD43
Mantle cell